Uniklinikum Erlangen

Essen, North Rhine-Westphalia 45147

1 studies enrolling now · 1 studies all time

What they study most

Leukemia Relapse, Leukemia and Lymphoma, Lymphoma Diffuse Large B-cell, Lymphoma Receiving CAR-T Therapy

Studies at this site

• Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies — Recruiting now